Fig. 1From: Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort studyThe cumulative event- free survival analysis for occurrence of MACE according to (a) glycemic status, HTN, and DLP, (b) glycemic status and HTN, (c) glycemic status and DLP, (d) IFG, DM, HTN, and DLP alone. MACE; major adverse cardiovascular events, NFG; normal fasting glucose, IFG; impaired fasting glucose, DM; diabetes mellitus, HTN; hypertension, DLP; dyslipidemiaBack to article page